Viamet

Viamet discovers and develops small molecule inhibitors through enzyme binding methods for the treatment of various diseases. The company has discovered and developed "best-in-class" inhibitors of validated metalloenzymes via its innovative and proprietary metal-binding approach, known as the Metallophile™ technology.